The Alvarez & Marsal Unsecured Creditors’ Committee Team is proud to represent the Official Committee of Unsecured Creditors of OptioRx. https://okt.to/BuL2U5 #Amon #UCC #UnsecuredCreditorsCommittee #Restructuring #Bankruptcy #Pharma
Alvarez & Marsal’s Post
More Relevant Posts
-
Take note of these tips to smoothen the sell-side M&A process, enhance the company's attractiveness to buyers, and maximize value. Check out our AleharX article via the link in the comments. #mergersandacquisitions #sellside #AleharX
To view or add a comment, sign in
-
Chief Investment Officer at Family Office - investing in undervalued clinical stage biotech companies that are on the verge of major value creation events.
My up-to-date breakdown of CervoMed’s shares outstanding, warrants, and stock options. I’ve identified that RA Capital Management likely purchased 400,000 pre-funded warrants as part of the private placement. RA Capital is arguably the leading biotech investor in the country. The recent private placement led by RA Capital results in the participating institutional investors taking a position that will result in over 40% ownership on a fully-diluted basis after a positive Phase 2b read out in Q4. Read my argument below. https://lnkd.in/g2BFpkAe
To view or add a comment, sign in
-
Tips to effectively manage the M&A sell-side process, enhance the company's attractiveness to buyers, and maximize value. Check out our AleharX article via the link in the comments. #MergersandAcquisitions #SellSide #AleharX
To view or add a comment, sign in
-
Following an initial 180 day compliance period for failure to maintain the $1.00 minimum bid price, a company may request an additional 180-day compliance period if at the 180th day of the first compliance period, it meets the market value of publicly held shares continued listing requirement and all of the applicable initial listing requirements other than the bid price requirement. The company must also explicitly notify Nasdaq of its intent to cure, generally through a reverse split. If the company has publicly announced information (e.g., in an earnings release) indicating that it no longer satisfies the applicable listing criteria, it shall not be eligible for the additional compliance period. www.ALCLAW.com #SecuritiesLawBlog #NASDAQ #ALCLAW
To view or add a comment, sign in
-
Five9, Inc. (NASDAQ: FIVN) Rated "Moderate Buy" by Analysts https://lnkd.in/g--_Wkv8 #Five9 #NASDAQ #FIVN #stock #Outperform #Businesses #portfolio #solutions #analysts THE CORPORATE MAGAZINE
To view or add a comment, sign in
-
-
Re Fusionex Pte Ltd (Resorts World at Sentosa Pte Ltd, non-party) [2024] SGHC 51 is the first reported decision in Singapore where the courts have ordered a winding up on the basis of a special resolution. In our latest client update, our Partners Darrell Kim Boon Low and Aileen Chua discuss the recent reported decision of the High Court on section 125(1)(a) of the Insolvency, Restructuring and Dissolution Act 2018, and the considerations to take note of when a company is considering winding up by special resolution in certain circumstances. #singaporelaw #restructuring #insolvency #caselaw
To view or add a comment, sign in
-
SPAC Feed: Psyence Group Announces SEC Registration Filing with NASDAQ … – GlobeNewswire - https://lnkd.in/e4bnhiYu Psyence Group Announces SEC Registration Filing with NASDAQ … GlobeNewswire Source: Psyence Group Announces SEC Registration Filing with NASDAQ … –… #SPACs #SPACNews #SPAC #IPO #markets #news #capitalmarkets #trends #goingpublic
Psyence Group Announces SEC Registration Filing with NASDAQ … – GlobeNewswire
https://spacfeed.com
To view or add a comment, sign in
-
OMNI'S WEEKLY ROUNDUP: Read This Week's Top Restructuring and Bankruptcy Headlines - Aug 11, 2023 Click this link to get the full stories and more! https://bit.ly/3KBqpRW #business #debt #bankruptcy #corporate #corporatebankruptcy #restructuring #SCOTUS #PurduePharma #Amyris #biotech
Omni's Weekly Roundup 8/11/23
To view or add a comment, sign in
-
Head of Business & Commercial Director | Specialising in Sales & BD Recruitment in the European Chemical Industry | LinkedIn Top Recruiting Voice
𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐛𝐚𝐧𝐤𝐫𝐮𝐩𝐭𝐜𝐢𝐞𝐬 𝐚𝐭 𝐩𝐞𝐚𝐤 𝐢𝐧 2️⃣0️⃣2️⃣3️⃣ 2023 was a challenging year in the biotech space, we knew that. Just how challenging, however, is becoming increasingly obvious. Apart from 187 companies having to let some of their workforce go, there were 1️⃣8️⃣ 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐛𝐚𝐧𝐤𝐫𝐮𝐩𝐭𝐜𝐢𝐞𝐬 in 2023. This was the highest since 2010, dwarfing all other years by far, including 2022 which previously held the record (8 bankruptcies). Some of the bigger names that had to file were Sorrento, Infinity, and OncoSec Medical. Reasons included legal battles, unsuccessful mergers, and trial failures. 𝐇𝐨𝐰 𝐢𝐬 2024 𝐥𝐨𝐨𝐤𝐢𝐧𝐠? So far, so 𝘣𝘢𝘥 – Humanigen and Athersys have already filed in the first few days of the year. Healthcare has started the year as 3rd behind only industrials and consumer discretionary in bankruptcy filings per sector. S&P quoted high interest rates and a challenging labor market at the culprits. At the same time, investment seems to have picked up somewhat. Where will the industry go from here? #biotech #pharma #bankruptcy #trends -------- Hit the 🔔 & follow for weekly updates on European pharmaceutical and chemical industries. And some personal tales from a recruiter’s life. Sebastian
To view or add a comment, sign in
-
-
Top National Claims and Noticing Agent, Chief Executive Officer and President at Omni Agent Solutions
OMNI'S WEEKLY ROUNDUP: Read This Week's Top Restructuring and Bankruptcy Headlines - Aug 11, 2023 Click this link to get the full stories and more! https://bit.ly/3KBqpRW #business #debt #bankruptcy #corporate #corporatebankruptcy #restructuring #SCOTUS #PurduePharma #Amyris #biotech
To view or add a comment, sign in
Financial Consultant
2wCongratulation!